# CardioMEMS HF System Real-World Evidence Post-Approval Study

> **NCT06306573** · — · ENROLLING_BY_INVITATION · sponsor: **Abbott Medical Devices** · enrollment: 2500 (estimated)

## Conditions studied

- Heart Failure NYHA Class II
- Heart Failure NYHA Class III

## Interventions

- **DEVICE:** CardioMEMS HF System

## Key facts

- **NCT ID:** NCT06306573
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-12-15
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06306573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06306573, "CardioMEMS HF System Real-World Evidence Post-Approval Study". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT06306573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*